Daptomycin FDA Link

A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.

Also Known As:

Cubicin; Daptomycin, 9-L beta-Aspartic Acid; Deptomycin; LY-146032; Daptomycin, 9 L beta Aspartic Acid; LY 146032; LY146032; N- decanoyl- L- tryptophyl- L- asparaginyl- L- aspartyl- L- threonylglycyl- L- ornithyl- L- aspartyl- D- alanyl- L- aspartylglycyl- D- seryl- threo- 3- methyl- L- glutamyl- 3- anthraniloyl- L- alanine- epsilon1- lactone

Pharmalogical Action Categories:

Anti-Bacterial Agents

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Daptomycin: 1702
Lipids: 114793
- Lipopeptides: 626
  - Daptomycin: 1702
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Lipopeptides: 626
    - Daptomycin: 1702
  - Cyclic Peptides: 530
    - Daptomycin: 1702

Y Senda Selected Research

Y Senda Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure